103 related articles for article (PubMed ID: 12966928)
1. 94th annual meeting of the American Association for Cancer Research Washington, DC--July 11-14, 2003.
Lobert S
Oncol Nurs Forum; 2003; 30(5):741-2. PubMed ID: 12966928
[No Abstract] [Full Text] [Related]
2. Cyclo-oxygenase 2 and breast cancer prevention. Non-steroidal anti-inflammatory agents are worth testing in breast cancer.
Vainio H; Morgan G
BMJ; 1998 Sep; 317(7162):828. PubMed ID: 9748169
[No Abstract] [Full Text] [Related]
3. [Cancer prevention: congress report].
L'Allemain G
Bull Cancer; 2004 May; 91(5):457-9. PubMed ID: 15281286
[No Abstract] [Full Text] [Related]
4. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
5. Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
Lipsky PE; Abramson SB; Breedveld FC; Brook P; Burmester R; Buttgereit F; Cannon GW; Catella-Lawson F; Crofford LJ; Doherty M; Dougados M; DuBois RN; Froelich J; Garcia Rodriguez LA; Gibofsky A; Hernandez-Diaz S; Hochberg MC; Krause A; Liang MH; Machold K; Peloso PM; Raisz LG; Schayes B; Scheiman JM; Simon LS; Smolen J
J Rheumatol; 2000 Jun; 27(6):1338-40. PubMed ID: 10852251
[No Abstract] [Full Text] [Related]
6. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
7. Correspondence re: Cotterchio et al., Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 1213-1217, 2001.
Mokbel K; Singh-Ranger G; Kirkpatrick K
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):674; author reply 674. PubMed ID: 12101118
[No Abstract] [Full Text] [Related]
8. COX-2: a target for colon cancer prevention.
Marnett LJ; DuBois RN
Annu Rev Pharmacol Toxicol; 2002; 42():55-80. PubMed ID: 11807164
[TBL] [Abstract][Full Text] [Related]
9. [COX-2 expression in gastric cancers].
Sakamoto C
Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
[No Abstract] [Full Text] [Related]
10. Polyamines and cancer: old molecules, new understanding.
Gerner EW; Meyskens FL
Nat Rev Cancer; 2004 Oct; 4(10):781-92. PubMed ID: 15510159
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
12. COX provides missing link in mechanism of aspirin in colon cancer.
Wunsch H
Lancet; 1998 Jun; 351(9119):1864. PubMed ID: 9652680
[No Abstract] [Full Text] [Related]
13. [Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials].
Guastalla JP; Bachelot T; Ray-Coquard I
Bull Cancer; 2004 May; 91 Spec No():S99-108. PubMed ID: 15239337
[TBL] [Abstract][Full Text] [Related]
14. [Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications].
Bessa X; Piñol V; Elizalde JI; Castells A
Gastroenterol Hepatol; 2000 Dec; 23(10):483-90. PubMed ID: 11149225
[No Abstract] [Full Text] [Related]
15. [Selective cyclooxygenase-2 (COX-2) inhibitors. Beliefs, reality and hope].
Brune K
Orthopade; 1997 Sep; 26(9):804-6; discussion 807. PubMed ID: 9432666
[No Abstract] [Full Text] [Related]
16. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer.
Yamamoto DS; Viale PH
Clin J Oncol Nurs; 2003; 7(1):21-9. PubMed ID: 12629931
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in cancer research.
Golsteyn RM
Drug News Perspect; 2004; 17(6):405-16. PubMed ID: 15334191
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenease-2 and hepatocellular carcinoma: is it a target for prevention?
DuBois RN
Clin Cancer Res; 2001 May; 7(5):1110-1. PubMed ID: 11350871
[No Abstract] [Full Text] [Related]
19. The molecular perspective: cyclooxygenase-2.
Goodsell DS
Stem Cells; 2000; 18(3):227-9. PubMed ID: 10840077
[No Abstract] [Full Text] [Related]
20. [Prevention of cancer and Alzheimer disease with non-steroidal anti-inflammatory agents].
Marks F
Dtsch Med Wochenschr; 2001 Mar; 126(11):308-13. PubMed ID: 11296571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
